BAXBaxter International

1. Aug 19, 2026Appointment of John Rogers as CFO On August 18, 2026, Baxter International Inc. (the “Company”) appointed John Rogers as Executive Vice President and Chief Financial Officer (“CFO”), effective as of October 1, 2026 (the “Transition Date”)Director or officer change · Form 8-K
2. Aug 18, 2026Amendment to the Credit Agreement On August 18, 2026, Baxter International Inc. (the “Company”) entered into an amendment (“Amendment No. 2”) to the amended and restated five-year credit agreement dated June 11, 2025, among the Company, as Borrower Representative, Baxter Healthcare SA and Baxter World Trade SRL, as …Material agreement entered · Form 8-K
3. Aug 4, 2026On August 4, 2026, Baxter International Inc. (the “Company”) issued a press release announcing the commencement of cash tender offers (each, an “Offer” and together, the “Offers”) to purchase up to $500 million in aggregate purchase price (excluding accrued and unpaid interest) of one or more series of the Company’s …Other event · Form 8-K
4. Aug 4, 2026On July 31, 2026, Anita Zielinski notified Baxter International Inc. (the “Company”) of her decision to resign as the Company’s Interim Chief Financial Officer and Senior Vice President, Chief Accounting Officer and Controller, effective as of September 15, 2026, to join another company.Director or officer change · Form 8-K
5. Jul 30, 2026Effective July 29, 2026, the Company's Board of Directors declared a quarterly cash dividend of $0.01 per share of common stock. The dividend is payable on October 1, 2026, to stockholders of record as of August 28, 2026.Earnings release · Form 8-K
6. May 8, 2026Executive Severance and Change in Control Plan and Hider Offer Letter Amendment On May 4, 2026, the Compensation and Human Capital Committee of the Board of Directors (the “Board”) of Baxter International Inc. (the “Company”) approved the Baxter International Inc. Executive Severance and Change in Control Plan (the …Director or officer change · Form 8-K
7. Apr 30, 2026Effective April 29, 2026, the Company's Board of Directors declared a quarterly cash dividend of $0.01 per share of common stock. The dividend is payable on July 1, 2026, to stockholders of record as of May 29, 2026.Earnings release · Form 8-K
8. Mar 19, 2026Stockholder Engagement Baxter.Regulation FD disclosure · press release
9. Mar 16, 2026Transition of Joel Grade as CFO; Appointment of Anita Zielinski as Interim CFO On March 16, 2026, Baxter International Inc. (the “Company”) announced that, as of such date (the “Transition Date”), Joel Grade’s service as Executive Vice President and Chief Financial Officer (“CFO”) of the Company has ceased and, as of …Director or officer change · Form 8-K
10. Feb 12, 2026Appointment of Michael R. McDonnell On February 10, 2026, Baxter International Inc. (the “Company”) appointed Michael R. McDonnell to its Board of Directors (the “Board”), effective February 13, 2026.Earnings release · Form 8-K
11. Dec 22, 2025Final Results of Tender Offers On December 22, 2025 (the “Final Settlement Date”), Baxter International Inc. (the “Company”) effected the final settlement of the Company’s previously announced cash tender offers (each, a “Tender Offer” and together, the “Tender Offers”) to purchase (i) any and all of its 2.600% senior …Other event · Form 8-K

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.